Stock listing

VOR Stock Price, News, Filings & Events — Vor Biopharma Inc.

Selected listing: VOR · NASDAQ · USD · US

This page tracks Vor Biopharma Inc.'s VOR:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VOR:NASDAQ. VOR:NASDAQ is the stock-level entry point for investors researching Vor Biopharma Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vor Biopharma Inc. is a public company traded under the ticker VOR in the American market. The company has a market capitalization of approximately $1.04 billion. Vor Biopharma focuses on developing innovative therapies to treat cancer through its proprietary technology.

VOR:NASDAQUSDUSUpdated August 31, 2026
Vor Biopharma Inc. logo
Ticker
VOR:NASDAQ
Asset type
Stock
Market cap
$1.34B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Vor Biopharma Inc. VOR:NASDAQ stock context

This page tracks Vor Biopharma Inc.'s VOR:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VOR:NASDAQ. VOR:NASDAQ is the stock-level entry point for investors researching Vor Biopharma Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vor Biopharma Inc. is a public company traded under the ticker VOR in the American market. The company has a market capitalization of approximately $1.04 billion. Vor Biopharma focuses on developing innovative therapies to treat cancer through its proprietary technology.

Latest news from Vor Biopharma Inc.

All Vor Biopharma Inc. news →

Research Vor Biopharma Inc.

Alternate listings